Small interfering RNA-based molecular therapy of cancers
RNA interference (RNAi) has become a gold standard for validating gene function in basic life science research and provides a promising therapeutic modality for cancer and other diseases. This mini-review focuses on the potential of small interfering RNAs (siRNAs) in anticancer treatment, including...
Main Authors: | Guo, Wei, Chen, Wangbing, Yu, Wendan, Huang, Wenlin, Deng, Wuguo |
---|---|
Format: | Online |
Language: | English |
Published: |
Sun Yat-sen University Cancer Center
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845562/ |
Similar Items
-
RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth
by: Qin, Yu, et al.
Published: (2015) -
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
by: Miele, Evelina, et al.
Published: (2012) -
TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling
by: Fu, Lingyi, et al.
Published: (2014) -
High expression of Y-box-binding protein 1 correlates with poor prognosis and early recurrence in patients with small invasive lung adenocarcinoma
by: Zhao, Shilei, et al.
Published: (2016) -
Molecular Basis for the Immunostimulatory Potency of Small Interfering RNAs
by: Sioud, Mouldy, et al.
Published: (2006)